HBSAG-POSITIVE CHRONIC LIVER DISEASE: INHIBITION OF DNA POLYMERASE ACTIVITY BY VIDARABINECHADWICK RG; BASSENDINE MF; CRAWFORD EM et al.1978; BRIT. MED. J.; GBR; DA. 1978; NO 6136; PP. 531-533; BIBL. 13 REF.Article

CHRONIC PERSISTENT HEPATITIS: HEPATITIS B VIRUS MARKERS AND HISTOLOGICAL FOLLOW-UPCHADWICK RG; GALIZZI J JR; HEATHCOTE J et al.1979; ; GUT; GBR; DA. 1979; VOL. 20; NO 5; PP. 372-377; BIBL. 23 REF.Article

LEVAMISOLE THERAPY FOR HBSAG-POSITIVE CHRONIC LIVER DISEASECHADWICK RG; JAIN S; COHEN BJ et al.1980; SCAND. J. GASTROENTEROL.; ISSN 0036-5521; NOR; DA. 1980; VOL. 15; NO 8; PP. 973-978; BIBL. 30 REF.Article

PRIMARY LIVER CELL CANCER IN BRITAIN: A VIRAL AETIOLOGY.BASSENDINE MF; CHADWICK RG; LYSSIOTIS T et al.1979; BRIT. MED. J.; GBR; DA. 1979; NO 6157; PP. 166; BIBL. 5 REF.Article

ADENOSINE ARABINOSIDE THERAPY IN HB_SAG-POSITIVE CHRONIC LIVER DISEASE: A CONTROLLED STUDYBASSENDINE MF; CHADWICK RG; SALMERON J et al.1981; GASTROENTEROLOGY; ISSN 0016-5085; USA; DA. 1981; VOL. 80; NO 5; PART. 1; PP. 1016-1022; BIBL. 26 REF.Article